Clinical studies have demonstrated that patients who follow the recommended dose escalation schedule typically achieve better outcomes than those who remain at lower doses
Consistent with the direct assessment of insulin sensitivity (Fig
5a), suggesting that these proteins share the ability to exhibit haem-dependent dimerization
In a recently published phase II study conducted on 92 T2D patients with a BMI 27 kg/m 2 , a 2.18% decrease in HbA1c and a 15.6% reduction in body weight were confirmed in the group administered CagriSema once a week [102]
This is particularly common if alcohol is consumed in large amounts
[1] [2] The most commonly reported side effects in clinical trials were gastrointestinal, including nausea (occurring in 12-29% of patients), diarrhea, vomiting, constipation, and abdominal discomfort